Brief: Psyence Biomed Announces Strategic Ibogaine Investment
23/09/2026 12:04
BRIEF-Psyence Biomed Announces Strategic Ibogaine Investment Psyence Biomedical Ltd PBM.O:
PSYENCE BIOMED ANNOUNCES STRATEGIC IBOGAINE INVESTMENT
PSYENCE BIOMEDICAL -AGREES TO INVEST UP TO $5 MILLION IN PSYLABS, $2.40 MILLION COMMITTED
PSYENCE BIOMEDICAL - CO AND PSYLABS AGREE TO $9 MILLION VALUE-MATCHED SHARE EXCHANGE
PSYENCE BIOMEDICAL - POST-DEAL, PSYLABS TO HOLD 49.89% OF PSYENCE BIOMED, PSYENCE BIOMED 41.13% OF PSYLABS
Source text: ID:nGNX8m9Ck4
Further company coverage: PBM.O